5 Most Shorted Stocks Right Now

Page 5 of 5

1. BioXcel Therapeutics, Inc. (NASDAQ:BTAI)

Short Interest Percentage: 89.72%

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is a biotechnology company that seeks to use AI to develop new medicines. The stock is down a painful 81% year to date, as the firm has faced difficulties in gaining share in the hospital market, cut down its workforce, reoriented its drugs to other diseases, and worked with the FDA to resolve issues for a drug trial.

Insider Monkey’s Q2 2023 database of 910 hedge funds revealed that six had invested in BioXcel Therapeutics, Inc. (NASDAQ:BTAI). Out of these, the firm’s biggest shareholder is Phill Gross and Robert Atchinson’s Adage Capital Management through a stake worth $13 million.

Follow Bioxcel Therapeutics Inc. (NASDAQ:BTAI)

Disclosure: None.  You can also take a look at Billionaire Chris Rokos is Selling These 12 Stocks in 2023 and Buffett Stock Portfolio: Warren Buffett’s Recent Buys.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5